Private equity is becoming more and more influential in many healthcare specialties, including cardiology. This has prompted increased speculation about the impact such investments may have on patient outcomes.

For AI to achieve sweeping adoption across U.S. medicine, physicians will need to be assured they won’t be held liable should clinical algorithms make mistakes.

Congress has already adjourned for the year without taking action, but U.S. medical societies are hoping relief from significant Medicare cuts will arrive in early 2024. 

RBMA President-elect Pete Moffatt discusses how to contend with challenges such as staff shortages and reimbursement issues.

Medical imaging makes up 76% of all the FDA-cleared artificial intelligence clinical algorithms used for direct patient care.

Richard Heller, MD, a member of the RSNA Board and associate CMO for Rad Partners, explains the impact of the 2024 Medicare cuts and what is at stake.

Some 44 nurses from Seattle Children’s Hospital have signed onto a letter attributing the chaos to a “systemic crisis in pediatric mental health.”

Rad Partners' Nina Kottler, MD, explains what practices should consider when assessing artificial intelligence solutions in an era where there is little reimbursement.